Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Morgen, Evan & Company is a boutique investment banking firm that provides specialized financial advisory services to the healthcare and life sciences industries. The firm focuses on mergers and acquisitions, private placements of debt and equity, and strategic corporate development for biotechnology, pharmaceutical, and medical technology companies. With a deep understanding of the clinical and regulatory landscape, Morgen, Evan & Company assists emerging and middle-market firms in executing complex financial transactions. The firm is headquartered in New York and serves a global client base, often facilitating cross-border deals between North American, European, and Asian markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Morgen, Evan and Company.